| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/15/1995 | CA2178205A1 Method of selecting specific bacteriophages |
| 06/15/1995 | CA2177835A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/14/1995 | EP0657541A1 Novel entities for cancer therapy |
| 06/14/1995 | EP0657540A1 Novel entities for cancer therapy |
| 06/14/1995 | EP0657539A1 Novel entities for cancer therapy |
| 06/14/1995 | EP0657532A1 HIV-3 retrovirus strains and their use |
| 06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
| 06/13/1995 | US5424197 H. saimiri-HTLV-X region vector |
| 06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | WO1995015382A1 Binding structures directed against the ca55.1 antigen |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/06/1995 | CA1335798C Retroviral vector |
| 06/06/1995 | CA1335790C Influenza vaccine |
| 05/31/1995 | EP0655501A1 HIV-2 virus variants |
| 05/31/1995 | EP0655072A1 Equine herpesvirus glycoproteins |
| 05/31/1995 | CN1102996A Producing process for vaccine of foot and mouth disease |
| 05/30/1995 | US5420030 Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof |
| 05/30/1995 | US5420026 Self-assembling replication defective hybrid virus particles |
| 05/30/1995 | US5419907 Pathogenic porcine respiratory coronavirus |
| 05/26/1995 | WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | WO1995014084A1 Biological control agent comprising an isolated polyhedrosis virus |
| 05/26/1995 | WO1995014083A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/26/1995 | CA2176585A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/24/1995 | EP0654089A1 Recombinant equine herpesviruses |
| 05/24/1995 | EP0654086A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/24/1995 | EP0569428B1 Method for the diagnosis in vitro of hiv-1 virus infections |
| 05/24/1995 | EP0377676B1 Human erythroid-specific transcriptional enhancer |
| 05/24/1995 | DE3690028C2 Method and test kit for analysing a biological sample for antibodies against retroviruses |
| 05/24/1995 | CA2136381A1 Vector vaccines of bovine herpesvirus 1 |
| 05/23/1995 | US5418130 Phosphonium or ammonium halo-psoralen |
| 05/18/1995 | WO1995013392A1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 05/18/1995 | WO1995013365A1 Generation of high titers of recombinant aav vectors |
| 05/18/1995 | WO1995013081A1 Lymphotropic agents and vectors |
| 05/18/1995 | DE4326821A1 New cancer vaccine based on autologous, transfected tumour cells |
| 05/17/1995 | EP0652968A1 Defective adenoviruses and corresponding complementation lines |
| 05/17/1995 | EP0652967A1 Self-assembling replication defective hybrid virus particles |
| 05/17/1995 | EP0652705A1 Nucleic acids and methods of use thereof for controlling viral pathogens |
| 05/16/1995 | US5416021 Fibronectin binding protein-encoding DNA |
| 05/11/1995 | WO1995012682A2 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/11/1995 | WO1995012669A1 Expression of foreign genes using a replicating polyprotein producing virus vector |
| 05/11/1995 | WO1995012660A2 Recombinant p53 adenovirus methods and compositions |
| 05/11/1995 | CA2172815A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/10/1995 | EP0652287A2 Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease |
| 05/10/1995 | EP0651815A1 Modified baculovirus, method for obtaining it, and expression vectors obtained from said baculovirus. |
| 05/10/1995 | EP0651796A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena |
| 05/10/1995 | EP0651790A1 Type-c rotavirus cultures and uses therefor |
| 05/10/1995 | EP0651789A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 05/09/1995 | US5413927 Feline immunodeficiency virus isolate NCSU1Lb |
| 05/04/1995 | WO1995011984A2 Recombinant adenoviral vector and methods of use |
| 05/04/1995 | DE4432338A1 Impfstoff zur Verhinderung des reproduktiven und respiratorischen Syndroms bei Schweinen Vaccine for the prevention of reproductive and respiratory syndrome in pigs |
| 05/02/1995 | US5411861 Mapping protein binding domains |
| 04/26/1995 | EP0515484B1 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 04/26/1995 | CN1101941A Method for suspending, adsorbing and multiplicating virus of hepatitis A |
| 04/20/1995 | WO1995010624A1 Endosomolytically active particles |
| 04/20/1995 | WO1995010601A1 Methods for preserving recombinant viruses |
| 04/20/1995 | CA2172139A1 Endosomolytically active particles |
| 04/20/1995 | CA2158935A1 Methods for preserving recombinant viruses |
| 04/19/1995 | EP0648502A1 Live vaccine with enhanced stability |
| 04/19/1995 | EP0388466B1 NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME (ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE $i(IN VITRO) DIAGNOSIS OF HIGH BLOOD PRESSURE |
| 04/18/1995 | CA1335259C Composition of spent liquor from pulping process for antiviral medicine |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | DE4404625C1 Method for inactivating thermolabile viruses in biological material while retaining collagenous properties |
| 04/12/1995 | EP0647274A1 Recombinant baculoviruses containing insect cellular promoter |
| 04/12/1995 | CN1101289A Live combination vaccine |
| 04/11/1995 | US5405776 Genetic engineering |
| 04/11/1995 | US5405770 Heliothis subflexa cell line for the production of baculoviruses |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/05/1995 | EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
| 04/05/1995 | EP0646172A1 Recombinant entomopoxvirus |
| 04/05/1995 | EP0218625B1 Infectious bronchitis virus spike protein |
| 04/05/1995 | CA2133401A1 Live vaccine having an increased stability |
| 04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
| 04/04/1995 | US5403484 Viruses expressing chimeric binding proteins |
| 03/30/1995 | WO1995008634A1 Method for generating influenza a viruses bearing attenuating mutations in internal protein genes |
| 03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 03/30/1995 | CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 03/29/1995 | EP0644946A1 Vector particles resistant to inactivation by human serum |
| 03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/29/1995 | EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof |
| 03/23/1995 | WO1995007994A2 Recombinant alphavirus vectors |
| 03/23/1995 | WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 03/23/1995 | WO1995007715A1 Cd8+ cell antiviral factor |
| 03/23/1995 | WO1995005460A3 Feline immunodeficiency virus isolate ncsu 1 |
| 03/23/1995 | CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 03/16/1995 | WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 03/16/1995 | WO1994026886A3 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 03/15/1995 | EP0643453A1 Electrical connecting member for two male tabs |
| 03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
| 03/15/1995 | EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |
| 03/14/1995 | US5397696 Papua New Guinea human T-lymphotropic virus |
| 03/09/1995 | WO1995006743A2 Methods and compositions for the large scale production of recombinant adeno-associated virus |
| 03/08/1995 | CN1099798A Hepatitis a virus vaccine |
| 03/02/1995 | WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/02/1995 | DE4407859C1 Vector for liver-specific gene therapy |
| 03/01/1995 | EP0640685A1 A cell strain capable of separating and multiplying an EB virus, and a method of separating and multiplying an EB virus by means of the same |